Authors: Peyman, A Scheunemann, KH Will, DW Knolle, J Wehner, V Breipohl, G Stilz, HU Carniato, D Ruxer, JM Gourvest, JF Auberval, M Doucet, B Baron, R Gaillard, M Gadek, TR Bodary, S

Citation: A. Peyman et al., alpha(v)beta(3) antagonists based on a central thiophene scaffold, BIOORG MED, 11(15), 2001, pp. 2011-2015

Authors: Chico, TJA Chamberlain, J Gunn, J Arnold, N Bullens, SL Gadek, TR Francis, SE Bunting, S Horton, M Shepherd, L Lipari, MT Quan, C Knolle, J Stilz, HU Peyman, A Crossman, DC

Citation: Tja. Chico et al., Effect of selective or combined inhibition of integrins alpha(IIb)beta(3) and alpha(v)beta(3) on thrombosis and neointima after oversized porcine coronary angioplasty, CIRCULATION, 103(8), 2001, pp. 1135-1141

Authors: Peyman, A Gourvest, JF Gadek, TR Knolle, J

Citation: A. Peyman et al., Vitronectin receptor antagonists: Purine-based peptidomimetics, ANGEW CHEM, 39(16), 2000, pp. 2874-2877

Authors: Peyman, A Wehner, V Knolle, J Stilz, HU Breipohl, G Scheunemann, KH Carniato, D Ruxer, JM Gourvest, JF Gadek, TR Bodary, S

Citation: A. Peyman et al., RGD mimetics containing a central hydantoin scaffold: alpha(v)beta(3) vs alpha(IIb)beta(3) selectivity requirements, BIOORG MED, 10(2), 2000, pp. 179-182